NM_014141.6:c.3716-7_3716-6insTT
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_014141.6(CNTNAP2):c.3716-7_3716-6insTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.558 in 1,578,214 control chromosomes in the GnomAD database, including 252,035 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.57   (  25625   hom.,  cov: 33) 
 Exomes 𝑓:  0.56   (  226410   hom.  ) 
Consequence
 CNTNAP2
NM_014141.6 splice_region, intron
NM_014141.6 splice_region, intron
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  0.173  
Publications
3 publications found 
Genes affected
 CNTNAP2  (HGNC:13830):  (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017] 
CNTNAP2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
- cortical dysplasia-focal epilepsy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 7-148409383-C-CTT is Benign according to our data. Variant chr7-148409383-C-CTT is described in ClinVar as Benign. ClinVar VariationId is 516869.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.652  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CNTNAP2 | NM_014141.6 | c.3716-7_3716-6insTT | splice_region_variant, intron_variant | Intron 22 of 23 | ENST00000361727.8 | NP_054860.1 | ||
| LOC105375554 | XR_928094.2 | n.210-14692_210-14691insAA | intron_variant | Intron 1 of 3 | 
Ensembl
Frequencies
GnomAD3 genomes  0.574  AC: 86906AN: 151482Hom.:  25607  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
86906
AN: 
151482
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.293  AC: 59553AN: 203228 AF XY:  0.303   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
59553
AN: 
203228
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.556  AC: 793079AN: 1426614Hom.:  226410  Cov.: 30 AF XY:  0.558  AC XY: 396955AN XY: 711266 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
GnomAD4 exome 
 AF: 
AC: 
793079
AN: 
1426614
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
396955
AN XY: 
711266
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
21506
AN: 
32632
American (AMR) 
 AF: 
AC: 
13837
AN: 
44570
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
12007
AN: 
25858
East Asian (EAS) 
 AF: 
AC: 
13972
AN: 
39460
South Asian (SAS) 
 AF: 
AC: 
52508
AN: 
85412
European-Finnish (FIN) 
 AF: 
AC: 
34598
AN: 
53084
Middle Eastern (MID) 
 AF: 
AC: 
2697
AN: 
5702
European-Non Finnish (NFE) 
 AF: 
AC: 
609584
AN: 
1080750
Other (OTH) 
 AF: 
AC: 
32370
AN: 
59146
 ⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.385 
Heterozygous variant carriers
 0 
 15789 
 31577 
 47366 
 63154 
 78943 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 16646 
 33292 
 49938 
 66584 
 83230 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.574  AC: 86958AN: 151600Hom.:  25625  Cov.: 33 AF XY:  0.570  AC XY: 42224AN XY: 74094 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
86958
AN: 
151600
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
42224
AN XY: 
74094
show subpopulations 
African (AFR) 
 AF: 
AC: 
27225
AN: 
41346
American (AMR) 
 AF: 
AC: 
5982
AN: 
15258
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1614
AN: 
3458
East Asian (EAS) 
 AF: 
AC: 
1920
AN: 
5146
South Asian (SAS) 
 AF: 
AC: 
2968
AN: 
4804
European-Finnish (FIN) 
 AF: 
AC: 
6905
AN: 
10554
Middle Eastern (MID) 
 AF: 
AC: 
121
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
38676
AN: 
67742
Other (OTH) 
 AF: 
AC: 
1128
AN: 
2102
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.493 
Heterozygous variant carriers
 0 
 1745 
 3490 
 5236 
 6981 
 8726 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 740 
 1480 
 2220 
 2960 
 3700 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Asia WGS 
 AF: 
AC: 
1794
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Cortical dysplasia-focal epilepsy syndrome    Benign:2 
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Nov 19, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.